Prime Medicine, Inc. (PRME)

NASDAQ: PRME · Real-Time Price · USD

4.805

+0.455 (10.46%)

At close: Jul 14, 2025, 4:00 PM

4.800

-0.005 (-0.10%)

After-hours: Jul 14, 2025, 7:59 PM EDT

Prime Medicine Employees

Prime Medicine had 214 employees as of December 31, 2024. The number of employees decreased by 20 or -8.55% compared to the previous year.

Employees

214

Change (1Y)

-20

Growth (1Y)

-8.55%

Revenue / Employee

$17,972

Profits / Employee

-$943,977

Market Cap

629.56M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	214	-20	-8.55%
Dec 31, 2023	234	59	33.71%
Dec 31, 2022	175	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	94,300
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

PRME News

7 days ago - Prime Medicine: Pressing Forward With Lead Liver Targeting Indications - Seeking Alpha
6 weeks ago - Prime Medicine to Participate in Upcoming Investor Conferences - GlobeNewsWire
2 months ago - Prime Medicine Announces Strategic Restructuring to Focus on Opportunities in Large Genetic Liver Diseases, Cystic Fibrosis, and Partnered Programs Alongside CEO Leadership Transition - GlobeNewsWire
2 months ago - Prime Medicine Announces Breakthrough Clinical Data Showing Rapid Restoration of DHR Positivity After Single Infusion of PM359, an Investigational Prime Editor for Chronic Granulomatous Disease - GlobeNewsWire
2 months ago - Prime Medicine Reports First Quarter 2025 Financial Results and Provides Business Updates - GlobeNewsWire
4 months ago - Prime Medicine Unveils Program for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD) - GlobeNewsWire
4 months ago - Prime Medicine Reports Full Year 2024 Financial Results and Provides Business Updates - GlobeNewsWire
5 months ago - Prime Medicine to Present at TD Cowen 45th Annual Health Care Conference - GlobeNewsWire